0.205
0.00 (2.50%)
| Previous Close | 0.200 |
| Open | 0.200 |
| Volume | 13,500 |
| Avg. Volume (3M) | 623,345 |
| Market Cap | 115,909,256 |
| Price / Sales | 1.65 |
| Price / Book | 2.83 |
| 52 Weeks Range | |
| TTM Dividend Yield | 4.44% |
| Profit Margin | 1.98% |
| Operating Margin (TTM) | -13.37% |
| Quarterly Revenue Growth (YOY) | 1.80% |
| Quarterly Earnings Growth (YOY) | -32.50% |
| Total Debt/Equity (MRQ) | 55.82% |
| Current Ratio (MRQ) | 4.95 |
| Operating Cash Flow (TTM) | 7.59 M |
| Levered Free Cash Flow (TTM) | -4.44 M |
| Return on Assets (TTM) | 4.52% |
| Return on Equity (TTM) | 2.65% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (MY) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | TOPVISN | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 1.25 |
|
Topvision Eye Specialist Bhd is principally involved in the provision of ophthalmology services and related medical consultancy services. It is also engaged in the marketing of eye supplements and health food products, and the retail sale of food and beverages. The company derives a majority of its revenue from its ophthalmology services business, providing treatments for general as well as complex eye diseases. Geographically, it operates in Malaysia. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Growth |
| % Held by Insiders | 61.48% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 24 Mar 2025 | Announcement | Changes in Director's Interest (Section 219 of CA 2016) - DATUK LIEW HOCK NEAN |
| 24 Mar 2025 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MADAM ANGELA LOO VOON PEI |
| 24 Mar 2025 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DATUK LIEW HOCK NEAN |
| 06 Mar 2025 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DATUK LIEW HOCK NEAN |
| 06 Mar 2025 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MADAM ANGELA LOO VOON PEI |
| 06 Mar 2025 | Announcement | Changes in Director's Interest (Section 219 of CA 2016) - DATUK LIEW HOCK NEAN |
| 05 Mar 2025 | TheEdge | Metro Healthcare focusing on maternity healthcare expansion |
| 03 Mar 2025 | Announcement | TOPVISN - Notice of Book Closure |
| 28 Feb 2025 | Announcement | Final Dividend |
| 28 Feb 2025 | Announcement | Quarterly rpt on consolidated results for the financial period ended 31/12/2024 |
| TTM Dividend Yield | 4.44% |
| Expected Next Dividend Payment | Jul 2026 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 26 Jun 2025 | 28 Feb 2025 | 21 Jul 2025 | 0.01 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2025 | 0.010 | 1 | 4.88 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |